This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 May;5(5):246-7.

doi: 10.1038/ncpuro1056. Epub 2008 Mar 25.

Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?

Joseph Presti Jr¹

Affiliations

PMID: 18364716
DOI: 10.1038/ncpuro1056

Comment

Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?

Joseph Presti Jr. Nat Clin Pract Urol. 2008 May.

. 2008 May;5(5):246-7.

doi: 10.1038/ncpuro1056. Epub 2008 Mar 25.

Author

Joseph Presti Jr¹

Affiliation

¹ Urologic Oncology Program, Stanford University School of Medicine, Stanford, CA 94305-5826, USA.

PMID: 18364716
DOI: 10.1038/ncpuro1056

No abstract available

PubMed Disclaimer

Comment on

Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Welch HG, et al. J Natl Cancer Inst. 2007 Sep 19;99(18):1395-400. doi: 10.1093/jnci/djm119. Epub 2007 Sep 11. J Natl Cancer Inst. 2007. PMID: 17848671

Similar articles

PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
Shimbo M, Tomioka S, Sasaki M, Shima T, Suzuki N, Murakami S, Nakatsu H, Shimazaki J. Shimbo M, et al. Jpn J Clin Oncol. 2009 Nov;39(11):727-31. doi: 10.1093/jjco/hyp091. Epub 2009 Aug 12. Jpn J Clin Oncol. 2009. PMID: 19674994
Strategy for repeat prostate biopsy: predictors of positive biopsy and additional biopsy location.
Katto K, Takahashi M, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Oka N, Fukumori T, Nishitani MA, Kanayama HO. Katto K, et al. Urol Int. 2008;81(2):173-8. doi: 10.1159/000144056. Epub 2008 Aug 29. Urol Int. 2008. PMID: 18758215
Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS. Tan N, et al. J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15. J Urol. 2008. PMID: 18707706
Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
Punnen S, Nam RK. Punnen S, et al. Surg Oncol. 2009 Sep;18(3):192-9. doi: 10.1016/j.suronc.2009.02.006. Epub 2009 Mar 12. Surg Oncol. 2009. PMID: 19282170 Review.
The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
Lawrentschuk N, Fleshner N. Lawrentschuk N, et al. BJU Int. 2009 Mar;103(6):730-3. doi: 10.1111/j.1464-410X.2008.08205.x. Epub 2009 Jan 14. BJU Int. 2009. PMID: 19154475 Review.

See all similar articles

Cited by

Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.
Jadvar H. Jadvar H. Abdom Radiol (NY). 2016 May;41(5):889-98. doi: 10.1007/s00261-015-0563-0. Abdom Radiol (NY). 2016. PMID: 27193789 Free PMC article. Review.
Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy.
Han M, Chang D, Kim C, Lee BJ, Zuo Y, Kim HJ, Petrisor D, Trock B, Partin AW, Rodriguez R, Carter HB, Allaf M, Kim J, Stoianovici D. Han M, et al. J Urol. 2012 Dec;188(6):2404-9. doi: 10.1016/j.juro.2012.07.107. Epub 2012 Oct 22. J Urol. 2012. PMID: 23088974 Free PMC article.
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.
Mitran B, Thisgaard H, Rinne S, Dam JH, Azami F, Tolmachev V, Orlova A, Rosenström U. Mitran B, et al. Sci Rep. 2019 Nov 19;9(1):17086. doi: 10.1038/s41598-019-52914-y. Sci Rep. 2019. PMID: 31745219 Free PMC article.
Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.
Mitterberger MJ, Aigner F, Horninger W, Ulmer H, Cavuto S, Halpern EJ, Frauscher F. Mitterberger MJ, et al. Eur Radiol. 2010 Dec;20(12):2791-6. doi: 10.1007/s00330-010-1860-1. Epub 2010 Jun 23. Eur Radiol. 2010. PMID: 20571801
Advancements in magnetic resonance-guided robotic interventions in the prostate.
Macura KJ, Stoianovici D. Macura KJ, et al. Top Magn Reson Imaging. 2008 Dec;19(6):297-304. doi: 10.1097/RMR.0b013e3181aa68b8. Top Magn Reson Imaging. 2008. PMID: 19512852 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database